Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax

Journal of Infectious Diseases

Volumn 204, Issue 9, 2011, Pages 1321-1327

  Boyer, Anne E ^a   Quinn, Conrad P ^a   Beesley, Cari A ^a   Gallegos Candela, Maribel ^a   Marston, Chung K ^a   Cronin, Li X ^a   Lins, Renato C ^b   Stoddard, Robyn A ^a   Li, Han ^a   Schiffer, Jarad ^a   Hossain, M Jahangir ^c   Chakraborty, Apurba ^c   Rahman, Mahmudur ^d   Luby, Stephen P ^a   Shieh, Wun Ju ^a   Zaki, Sherif ^a   Barr, John R ^a   Hoffmaster, Alex R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c International Centre for Diarrhoeal Disease Research   (United States)

^d Institute of Epidemiology Disease Control and Research   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN G;

ACUTE DISEASE; ANTHRAX; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACILLUS ANTHRACIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; BIOLOGICAL WARFARE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; EPIDEMIC; HUMAN; IMMUNOHISTOCHEMISTRY; LETHAL GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROCONVERSION; SERODIAGNOSIS; SKIN ANTHRAX; SYMPTOMATOLOGY; TOXEMIA;

ANIMALS; ANTHRAX; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, BACTERIAL; ANTITOXINS; BACTERIAL TOXINS; BANGLADESH; DISEASE OUTBREAKS; HUMANS; IMMUNOGLOBULIN G;

EID: 80053401092     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir543     Document Type: Article

References (24)

1. Wallace R, ed. Maxcy-Rosenau-Last public health & preventive medicine. 15th ed. New York: McGraw-Hill Companies, 2008.
2. Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8:1019-28. (Pubitemid 35256987)
3. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001; 7:933-44. (Pubitemid 33115771)
4. Turk BE. Manipulation of host signalling pathways by anthrax toxins. Biochem J 2007; 402:405-17. (Pubitemid 46423878)
5. Duesbery NS,Webb CP, Leppla SH, et al. Proteolytic inactivation ofMAPkinase-kinase by anthrax lethal factor. Science 1998; 280:734-7. (Pubitemid 28243347)
6. Leppla SH. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 1982; 79:3162-6. (Pubitemid 12008374)
7. Wright JG, Quinn CP, Shadomy S, Messonier N. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009.MMWRRecomm Rep 2010; 59(RR-6):1-30.
8. Quinn CP, Dull PM, Semenova V, et al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis 2004; 190:1228-36. (Pubitemid 39287748)
9. Programme on Infectious Disease and Vaccine Sciences, ICDDR,B and Institute of Epidemiology, Disease Control and Research (IEDCR), Ministry of Health and Family Welfare, Department of Livestock Services (DLS), Government of the People's Republic of Bangladesh. Cutaneous anthrax outbreaks in two districts of North-Western Bangladesh, August-October, 2009. Health and Science Bulletin December 2009. Bangladesh: International Centre for Diarrhoeal Disease Research, 2009.
10. Boyer AE, Quinn CP, Woolfitt AR, et al. Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal Chem 2007; 79:8463-70. (Pubitemid 350171353)
11. Li H, Soroka SD, Taylor TH Jr, et al. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization. J Immunol Methods 2008; 333:89-106.
12. Quinn CP, Semenova VA, Elie CM, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002; 8:1103-10. (Pubitemid 35257002)
13. Boyer AE, Quinn CP, Hoffmaster AR, et al. Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect Immun 2009; 77:3432-41.
14. Owen MP, Kiernan JA. The M'Fadyean reaction: a stain for anthrax bacilli. Biotech Histochem 2004; 79:107-8.
15. Popovic T, Hoffmaster A, Ezzell JW, Abshire TG, Brown JE. Validation of methods for confirmatory identification of presumptive isolates of Bacillus anthracis. J AOAC Int 2005; 88:175-7. (Pubitemid 40207028)
16. Tatti KM, Greer P, White E, et al. Morphologic, immunologic, and molecular methods to detect Bacillus anthracis in formalin-fixed tissues. Appl Immunohistochem Mol Morphol 2006; 14:234-43. (Pubitemid 43941192)
17. Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP. A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials. Biologicals 2010; 38:675-83.
18. Lucey D. Bacillus anthracis (anthrax). In: Mandell GL, Bennett JE, Dolin R eds. Mandell, Douglas, and Bennet's principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, 2005: 2485-91.
19. Quinn C, Turnbull P. Anthrax. In: Collier L, Balows A, SussmanMeds. Topley & Wilson's microbiology and microbial infections. 9th ed. New York: Oxford University Press, 1998:799-818.
20. Shieh WJ, Guarner J, Paddock C, et al. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol 2003; 163:1901-10. (Pubitemid 37310020)
21. de Lalla F, Ezzell JW, Pellizzer G, et al. Familial outbreak of agricultural anthrax in an area of northern Italy. Eur J Clin Microbiol Infect Dis 1992; 11:839-42.
22. Walsh JJ, Pesik N, Quinn CP, et al. A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis 2007; 44:968-71. (Pubitemid 46452063)
23. Brenneman KE, Doganay M, Akmal A, et al. The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax. FEMS Immunol Med Microbiol 2011; 62:164-72.
24. Boyer AE, Gallegos-Candela M, Lins RC, et al. Quantitative mass spectrometry for bacterial protein toxins-a sensitive, specific, highthroughput tool for detection and diagnosis. Molecules 2011; 16: 2391-413.